RxDoctor Payments Data

Margaret Sellers, PA

Medical · Atlanta, GANPI 1871012526

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.0% of the total across 512 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,831in general payments, 2019–2025

Across 512 payments — averaging $21.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • AbbVie$2K
  • Johnson & Johnson$1K
  • Novartis$1K
  • AstraZeneca$705
  • UCB, Inc.$603
  • plus $3K from 25 others

What the payments were for

  • Food & beverage$10,72699%
  • Education$1051%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,831 in reported general payments places this provider in the 95th percentile of 950 medical providers in Georgia.

See all medical providers in Georgia

Medicare billing

Part B allowed, 2024
$18,996
Medicare patients
147
Services billed
1,035

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab12$102,921
Hydroxychloroquine Sulfate61$2,289
Celecoxib50$2,000
Cevimeline Hcl12$1,708
MethotrexateMethotrexate Sodium43$1,179
Leflunomide18$1,082
Pregabalin23$824
Duloxetine Hcl24$673
Prednisone129$567
Gabapentin25$202
Tizanidine Hcl29$155
Methylprednisolone11$126
Folic Acid11$62
Meloxicam16$57
Tramadol Hcl16$52

Paid to pharmacies, not to this prescriber.

Other medical in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →